Otolin-1 Inhibitors
Otolin-1 inhibitors are chemicals that act on various cellular pathways to modulate the function and interactions of Otolin-1, primarily within the extracellular matrix (ECM) and inner ear otoconia. MEK inhibitors like PD98059 target the MAPK pathway and indirectly affect Otolin-1 by disrupting negative feedback mechanisms involving SPRY4. Other inhibitors, such as SP600125, a JNK inhibitor, can dampen AP-1 transcriptional activity, which is essential for the expression of ECM proteins that collaborate with Otolin-1. ROCK inhibitors like Y-27632 modulate cytoskeletal interactions that influence Otolin-1's role in otoconia, providing another layer of control.
In addition to these, the PI3K inhibitors LY294002 and Wortmannin modulate AKT signaling pathways, affecting the cellular architecture where Otolin-1 serves its anchoring functions. GSK-3β inhibitors like CHIR99021 can interfere with Wnt pathways that influence Otolin-1's role in ECM formation. The diversity in these inhibitors highlights the multi-faceted control mechanisms that can be employed to modulate Otolin-1's functions, whether it is the formation of the ECM or the development and maintenance of inner ear otoconia.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that dampens the MAPK pathway. SPRY4, a negative feedback regulator within this pathway, can alter its expression, indirectly affecting Otolin-1-linked ECM assembly. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that reduces the AP-1 transcriptional activity, which plays a role in the expression of ECM proteins, impacting the Otolin-1-mediated ECM assembly. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor that affects actin dynamics and thereby modulates the cytoskeletal interactions with Otolin-1 in otoconia. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that impairs AKT signaling, altering the cellular matrix where Otolin-1 usually performs its anchoring functions. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor which can lead to decreased expression of Otolin-1 by disrupting the MK2/3 pathway. | ||||||
Tyrphostin B42 | 133550-30-8 | sc-3556 | 5 mg | $26.00 | 4 | |
JAK-STAT inhibitor that may affect Otolin-1 through modulation of STAT-activated genes involved in extracellular matrix formation. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
Wnt production inhibitor that can suppress Wnt pathway, affecting ECM assembly, which is a functional realm of Otolin-1. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Gamma-secretase inhibitor that can influence Notch signaling and thereby the expression of Otolin-1, as they both play roles in inner ear development. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that impacts the Akt pathway, potentially altering intracellular localization of Otolin-1. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
GSK-3β inhibitor that affects the Wnt pathway, potentially altering the stability of Otolin-1's function in ECM formation. | ||||||